Literature DB >> 7662598

Furosemide dynamics in conscious rabbits: modulation by angiotensin II.

W Homsy1, S Marleau, P du Souich.   

Abstract

The aim of this study was to investigate the effects of an infusion of angiotensin II (50 ng/kg/min) on furosemide pharmacodynamics and kinetics in the conscious rabbit. The protocol included a 90-minute phase to estimate the glomerular filtration rate and the renal plasma flow, followed by a 60-minute phase where 5 mg/kg (n = 12) or 10 mg/kg (n = 9) of furosemide were administered. During the pre-furosemide phase, compared to control rabbits, angiotensin II increased natriuresis and diuresis. In the presence of angiotensin II, the furosemide-induced natriuresis decreased, that is, it was 174 +/- 14 versus 95 +/- 25 mumol/min (p < 0.05) and 187 +/- 17 versus 89 +/- 21 mumol/min (p < 0.05) for the 5 and the 10 mg/kg doses, respectively. The infusion of angiotensin II decreased renal plasma flow without modifying the glomerular filtration rate, thus the filtration fraction was increased. Angiotensin II increased the area under the furosemide plasma concentrations as a function of time since it decreased its systemic clearance. However, furosemide urinary excretion rate was not altered and its renal clearance decreased slightly without reaching statistical significance. It is concluded that angiotensin II decreases the response to furosemide and the mechanism underlying this effect is related to the pharmacodynamics rather than the kinetics of the diuretic.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7662598     DOI: 10.1007/bf00878676

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  45 in total

Review 1.  Mechanisms underlying pressure-related natriuresis: the role of the renin-angiotensin and prostaglandin systems. State of the art lecture.

Authors:  J C Romero; F G Knox
Journal:  Hypertension       Date:  1988-06       Impact factor: 10.190

2.  Effect of furosemide administration and upright position on plasma renin activity and angiotensin II in hypertension.

Authors:  S Fukuchi; T Takenouchi; K Nakajima
Journal:  Tohoku J Exp Med       Date:  1973-09       Impact factor: 1.848

3.  Inhibition of renin secretion by systemic and intrarenal angiotensin infusion.

Authors:  J R Blair-West; J P Coghlan; D A Denton; J W Funder; B A Scoggins; R D Wright
Journal:  Am J Physiol       Date:  1971-05

Review 4.  Intrarenal and systemic actions of the renin-angiotensin system. Implications for renal excretory function and sodium homeostasis.

Authors:  N K Hollenberg
Journal:  Contrib Nephrol       Date:  1984       Impact factor: 1.580

Review 5.  The renin-angiotensin system in the control of systemic arterial pressure.

Authors:  A B Ribeiro; O Kohlmann; M A Saragoça; O Marson; O L Ramos
Journal:  Drugs       Date:  1985       Impact factor: 9.546

Review 6.  Control of sodium excretion by angiotensin II: intrarenal mechanisms and blood pressure regulation.

Authors:  J E Hall
Journal:  Am J Physiol       Date:  1986-06

7.  Acute tolerance development to the diuretic effect of furosemide in the rat.

Authors:  M Hammarlund; L K Paalzow
Journal:  Biopharm Drug Dispos       Date:  1985 Jan-Mar       Impact factor: 1.627

8.  Furosemide disposition in cirrhosis.

Authors:  R K Verbeeck; R V Patwardhan; J P Villeneuve; G R Wilkinson; R A Branch
Journal:  Clin Pharmacol Ther       Date:  1982-06       Impact factor: 6.875

9.  Mechanisms of reduced effects of loop diuretics in healthy volunteers and in patients with renal disease.

Authors:  P Sjöström
Journal:  Scand J Urol Nephrol Suppl       Date:  1988

10.  Biotransformation of furosemide in kidney transplant patients.

Authors:  D E Smith; L Z Benet
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

View more
  2 in total

1.  The influence of moderate hypoalbuminaemia on the renal metabolism and dynamics of furosemide in the rabbit.

Authors:  V Pichette; D Geadah; P du Souich
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 2.  Clinical pharmacokinetics and pharmacodynamics of aliskiren.

Authors:  Sujata Vaidyanathan; Venkateswar Jarugula; Hans Armin Dieterich; Dan Howard; William P Dole
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.